Our profiling and comparison on the actions of conolidine and cannabidiol with known pharmacological agents predicted a MOA shared with Cav2.2 channel blocker, ω-conotoxin CVIE. In 2011, the halls of the Scripps Exploration Institute in Jupiter, Florida witnessed the inception of a scientific journey that may redefine our knowledge https://assisil506gyo2.wikidank.com/user